Back to search

Axol Bioscience Ltd

08340031

active
Private Limited Company
england wales
Companies House
Health Score
88 / 100

Healthy

30/30
Filing
20/30
Financial
38/40
Risk
  • 1 outstanding charge (-2)

Details

MEDITRINA BUILDING BABRAHAM BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT
Incorporated 21/12/2012

Compliance

Last accounts

31/12/2025

small

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 24/07/2026

Due 07/08/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Dr Derek John Trezise

director · Since 27/05/2020

RESEARCH SCIENTIST

BRITISH · ENGLAND · Age 59

Also on 3 other boards

Mr Liam Mark Taylor

director · Since 03/09/2020

CHIEF EXECUTIVE

AUSTRALIAN · WALES · Age 49

Also on 2 other boards

Dr Harry Thomas Stratford

director · Since 16/03/2021

EXECUTIVE

BRITISH · SCOTLAND · Age 55

Also on 3 other boards

Mr Oliver Richardson

director · Since 31/10/2022

FINANCE DIRECTOR

ENGLISH · ENGLAND · Age 31

Also on 2 other boards

Persons with Significant Control

Censo Biotechnologies Ltd

75–100% shares
75–100% votes

Roslin Innovation Centre, Charnock Bradley Building, Midlothian, EH25 9RG

Reg: Sc348293 · Companies House, Registrar Of Companies For Scotland · Private Limited Company

Notified 16/03/2021

Former PSCs

Dr Yichen Shi

Ceased 16/03/2021

Charges1 outstanding

A registered charge
outstanding

Broadoak Fund Vi, L.P. (As Security Trustee)

Created 24/12/2025Registered 31/12/2025

CompanyRankvs 411+ SIC 72110 peers
65

Financial strength90th percentile among SIC peers · 23/25
Employees22th percentile among SIC peers · 3/15
LiquidityCurrent ratio 135.98× · 20/20
Longevity14 years trading (max 15) · 14/15
Filing complianceAll filings up to date · 15/15
Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity14/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£596k

Balance sheet strength

Cash

£655

Cash in the bank

Net Current Assets

£596k

Working capital

Current Assets

£601k

Current Liabilities

£4k

Fixed Assets

£1

Debtors

£600k

0avg. employees

Balance Sheet

Bank loans & overdrafts£4k
Assets less current liabilities£596k
Prepared with Caseware UK (AP4) 2025.0.111

EstimatesDerived

YearCurrent Ratio
2025135.98

Derived from filed accounts. Not audited figures.